|
MicroRNAs involved in immune response as prognostic markers in early and metastatic breast cancer. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Vifor Pharma (I) |
Consulting or Advisory Role - MSD; Roche |
Research Funding - AstraZeneca (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; Genesis Pharmaceuticals; Roche |